Pathios Therapeutics: Funding, Investors & Team (Sep 2026)
Pathios Therapeutics is a biotechnology firm with a primary focus on creating treatments for autoimmune diseases and cancer.
Pathios Therapeutics has raised $25.7M across 2 funding rounds on record, the most recent a Series B of $25.0M announced in Apr 2024.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Pathios Therapeutics Company Profile and Key Stats
Latest funding round on record: Apr 2024.
Pathios Therapeutics Funding Rounds
Pathios Therapeutics raised $690k in an undisclosed round announced in Sep 2023.
7 months later, a Series B of $25.0M was announced in Apr 2024.
Pathios Therapeutics Founders and Leadership Team
Contact details for the Pathios Therapeutics team: 1 of 1 has an email address on file.
Start 14-day free trial →Pathios Therapeutics Funding Compared to Other Biotechnology Startups
Pathios Therapeutics' latest round of $25.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Pathios Therapeutics in Biotechnology and Oxford
Companies Similar to Pathios Therapeutics
Alchemab is harnessing the naturally protective power of patient antibodies to keep people free of…
Biodexa Pharmaceuticals is an international specialty pharmaceutical company focused on oncology and other…
Concert Bio helps businesses create optimal microbial communities.
RQ Bio is a biotechnology company that develops long-acting monoclonal antibodies against seasonal influenza…
N4 Pharma is a drug reformulation company focused on developing and out licensing new versions of existing…
Laverock Therapeutics is working on developing a system for suppressing genes, which can be used to create…
Oak hill bio is a clinical-stage rare disease therapeutics company developing life-changing medicines.
IMU is a discovery engine mapping the immune system to advance precision medicine.
Mykor is a climate tech start-up. It decarbonizes the construction industry by manufacturing carbon-negative…
Neurovalens provides cutting-edge solutions in the realms of neuroscience, bioscience, and neurophysiology.…
Voxmind's biometric confirmation and authentication platform that provides voice based biometrics that helps…
Five is a biometric payment services company that offers thumb recognition technology for safe transactions.
Pathios Therapeutics Funding FAQs
What does Pathios Therapeutics do?
Pathios Therapeutics is a biotechnology firm with a primary focus on creating treatments for autoimmune diseases and cancer.
How much funding has Pathios Therapeutics raised?
Pathios Therapeutics has raised $25.7M across 2 rounds on record. The most recent is a Series B of $25.0M announced in Apr 2024.
When did Pathios Therapeutics last raise funding?
Pathios Therapeutics' most recent funding round on record is a Series B of $25.0M, announced in Apr 2024.
Who founded Pathios Therapeutics?
FundedIQ lists Kirsty Mccarthy (Founder) at Pathios Therapeutics.
Where is Pathios Therapeutics headquartered?
Pathios Therapeutics is based in Oxford, Oxfordshire, United Kingdom.
How many employees does Pathios Therapeutics have?
Pathios Therapeutics is in the 11-50 employee band.
How does Pathios Therapeutics' funding compare to other Biotechnology startups?
Pathios Therapeutics' latest round of $25.0M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's Pathios Therapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Pathios Therapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.